P-191: Association of STK11 Gene Polymorphisms with Methformin Treatment in Patients with Polycystic Ovary Syndrome

Authors

  • Afsharian P
  • Ahmadi J
  • Khosravifar M
  • Shiva M
  • Tarahomi N
Abstract:

Background: Metformin is an insulin sensitizing drug, which is co-administered with Clominophene citrate or gonadotropins in most cases of polycystic ovary syndrome (PCOS), to improve ovulation. STK11 gene is necessary for action of metformin. Therefore the study of STK11 polymorphisms is important as pharmacogenetics aspects of metformin. The aim of our study was to investigate polymorphism of STK11 gene in PCOS patients (40 people) in comparison to 2 other groups used as fertile (40 people) and drug response-control (40 people) groups to clarify whether any differences between three groups exists in observed single nucleotide polymorphisms (SNPs). Materials and Methods: Multiple polymorphisms of STK11 were examined on DNA isolated from blood samples. In exons 6, 8 we used Polymerase chain reactionrestriction fragment length polymorphism (PCR- RFLP) while sequencing was undertaken to study exon 4, introns 1and 3 to detect known SNPs. Two amino acids of active site in exon 4 were also studied. Results: The results indicated that polymorphism in intron 1 of STK11 was associated with PCOS.The highest percentage of individuals with GG genotype (37.5%) was in PCOS group. Individuals with this genotype had high insulin level and showed better response to treatment with metformin. Our fertile control group has showed 7.5% of GG genotype. Conclusion: In total, 40% (48 out of 120) of our studied population, were shown SNP (rs2075606) (T>C) in intron 3. Data showed SNPs of exons 4, 6, 8 were not associated with PCOS. No amino acid change was observed in active site of this gene.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

P-216: Common Polymorphisms of StAR Gene Are Not Associated with Polycystic Ovary Syndrome in Iranian Patients

Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders, affecting 5-10% of reproductive aged women. High levels of androgen hormone can be accounted as the most important symptoms in PCOS. Androgen is the precursor of steroid biosynthesis in ovary. The transport of cholesterol to the inner mitochondrial membrane through StAR protein is also necessary for andr...

full text

Metabolic Syndrome in Patients with Polycystic Ovary Syndrome in Iran

Background The prevalence of metabolic syndrome (MetS) in polycystic ovary syndrome (PCOS) has been studied in different populations, but their results were so controversial regarding Iranian women. These controversial data indicated the need for more investigation of MetS characteristics in PCOS patients in our population. So this study aimed to evaluate the clinical and laboratory characteris...

full text

P-192: Association of Cytochrome P450 2D6 (CYP2D6) Gene Polymorphism with Clomiphene Citrate Treatment in Iranian Infertile Women with Polycystic Ovary Syndrome

Background: Clomiphene Citrate (CC) is the most frequently administered drug for the treatment of female infertility [e.g. polycystic ovary syndrome (PCOS)]; which aims at restoring ovulation. Clomiphene is metabolized by CYP2D6, an important enzyme responsible for the metabolism of approximately 25% of clinically used drugs. CYP2D6 is very polymorphic and thought to result in inter- individual...

full text

P-212: Ala 307 Thr Polymorphism of FSHR in Iranian Patients with Polycystic Ovary Syndrome (PCOS)

Background: Follicle stimulating hormone (FSH) receptor plays an important role in FSH signaling during reproductive development. Any changes in FSHR gene is resulted in alteration of amino acid in protein chain, consequence to affect the binding affinity, intracellular signaling and expression levels of FSHR. FSHR polymorphisms can be involved in etiology of many reproductive disorders such as...

full text

Association of polymorphisms of interleukin-18 gene promoter region with polycystic ovary syndrome in chinese population

BACKGROUND Recent research shows that polycystic ovary syndrome (PCOS) may have an association with low-grade chronic inflammation, and that PCOS may induce an increase in serum interleukin-18 (IL-18) levels. METHODS To investigate the polymorphisms of the IL-18 gene promoters with PCOS, two single nucleotide polymorphisms (SNPs) in the promoter of the IL-18 gene (at positions -607C/A and -13...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 7  issue 3

pages  111- 111

publication date 2013-09-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023